Digirad Corporation announced that it has completed its previously announced strategic partnership and investment into Perma-Fix Medical S.A. Under this partnership, Digirad invested $1 million into Perma-Fix Medical S.A. The investment constituted approximately 5.4% of the outstanding common shares of Perma-Fix Medical S.A. As part of the partnership and investment, Digirad appointed Matt Molchan, President and CEO of Digirad Corporation, to Perma-Fix Medical S.A.'s Supervisory Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 PLN | +1.59% | +10.34% | +216.83% |
1st Jan change | Capi. | |
---|---|---|
+216.83% | 2.12M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- RNT Stock
- News Private Rented Sector S.A.
- Matt Molchan to Join Supervisory Board of Perma Fix Medical SA